Variants within genes associated with Parkinson’s disease (PARK9;ATP13A2), neuronal ceroid lipofuscinosis (NCL;TPP1) and hereditary neuropathy (DNMT1) were also identified. This evidence concerns the gene ATP13A2 and infantile neuronal ceroid lipofuscinosis.